SCM
DRUG

Superstring Capital Management’s Bright Minds Biosciences DRUG Stock Holding History

Superstring Capital Management’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
30,456
+17,145
+129% +$1.35M 1.35% 22
2026
Q1 		$971K Sell
13,311
-33,967
-72% -$2.73M 0.69% 29
2025
Q4 		$3.69M Sell
47,278
-6,672
-12% -$446K 1.98% 18
2025
Q3 		$3.27M Buy
+53,950
New +$2.09M 3.22% 14

Other funds holding DRUG

JT
Jupiter Topco New York $245B AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Superstring Capital Management's DRUG Position: Q2 2026 in Review

Superstring Capital Management increased its Bright Minds Biosciences (DRUG) stake by 129% in Q2 2026, buying an estimated $1.35M and bringing the position to 30,456 shares worth $2.14M. The position accounts for 1.35% of the portfolio, ranked #22.

Superstring Capital Management first reported a position in DRUG in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.69M in Q4 2025. 100 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Superstring Capital Management held 30,456 shares of Bright Minds Biosciences worth $2.14M as of Q2 2026.
  • Superstring Capital Management bought 17,145 Bright Minds Biosciences shares in Q2 2026, an estimated $1.35M.
  • Bright Minds Biosciences made up 1.35% of Superstring Capital Management's portfolio in Q2 2026, its #22 holding.
  • Superstring Capital Management first reported a position in Bright Minds Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Superstring Capital Management's Bright Minds Biosciences position peaked at $3.69M in Q4 2025.
  • 100 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.